PT - JOURNAL ARTICLE AU - Diawara, Idrissa AU - Ahid, Samir AU - Jeddane, Leïla AU - Kim, Soyoun AU - Nejjari, Chakib TI - Saliva-based COVID-19 Rapid Antigen Test: a practical and accurate alternative mass screening method AID - 10.1101/2022.10.24.22278691 DP - 2022 Jan 01 TA - medRxiv PG - 2022.10.24.22278691 4099 - http://medrxiv.org/content/early/2022/10/26/2022.10.24.22278691.short 4100 - http://medrxiv.org/content/early/2022/10/26/2022.10.24.22278691.full AB - As SARS-CoV-2 and its variants continue to spread, a reliable and convenient alternative to nasopharyngeal swabbing and RT-PCR testing is needed. To test the usability and performance of saliva sample collection, saliva, nasal and nasopharyngeal swab specimens were collected from a total of 338 individuals consisting of confirmed COVID-19 patients and healthy subjects. To evaluate the diagnostic accuracy of self-collected and performed SARS-CoV-2 rapid antigen test on saliva and nasal swabs specimens, we compared its performance to nasopharyngeal swab specimen RT-PCR as a comparator test. In saliva specimens, the positive percent agreement was 90.14%, and the negative percent agreement was 99.61%, while in nasal swab specimens, the positive percent agreement was 91.55%, and the negative percent agreement was 100%, both meeting the sensitivity and specificity criteria required by the FDA. Therefore, when considering both the reliability and convenience of testing, we found saliva testing to be the better method for large-scale and frequent self-testing.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any external funding from a third party.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Review Board of Mohammed VI University of Health Sciences gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.